Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple injection ease chronic dry mouth?

NCT ID NCT07594184

Symptom relief Sponsor: University of Barcelona Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting hyaluronic acid into the mouth can relieve dry mouth symptoms in adults with xerostomia. Forty participants will receive either the treatment or a placebo and be followed for six months. The goal is to see if it improves comfort and saliva flow, and how long any benefit lasts.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hyaluronic acid
What this could lead to
If it works, this could offer a new way to relieve chronic dry mouth symptoms for people with xerostomia.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply to everyone. The treatment is compared to a placebo, and the effect may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 18 years of age * Patients reporting symptoms compatible with xerostomia for at least one year * Patients who agree to cooperate in the study, comply with the follow-up plan, and sign the informed consent Exclusion Criteria: * Underage patients * Pregnant patients * Patients on antiplatelet or anticoagulant therapy * Patients with a history of adverse reactions to hyaluronic acid infiltration * Patients with active infectious diseases in the oral cavity * Immunocompromised patients * Patients with other active diseases affecting the oral mucosa * Patients with uncontrolled autoimmune diseases * Patients allergic to lidocaine and/or mepivacaine * Patients undergoing active chemotherapy and/or radiotherapy for head and neck * Non-cooperative patients (e.g., psychomotor dysfunctions and behavioral disorders)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Xerostomia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Xerostomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Xerostomia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Odontologico Universidad de Barcelona

    RECRUITING

    Barcelona, Barcelona, 08907, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.